{"id":"NCT00463437","sponsor":"GlaxoSmithKline","briefTitle":"Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines","officialTitle":"Booster Vaccination With Pneumococcal Vaccine GSK1024850A, a DTPa-Combined and MenC or Hib-MenC Vaccines","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-04-25","primaryCompletion":"2008-01-21","completion":"2008-06-14","firstPosted":"2007-04-20","resultsPosted":"2009-08-03","lastUpdate":"2020-01-02"},"enrollment":1437,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Hepatitis B","Acellular Pertussis","Tetanus","Poliomyelitis","Diphtheria","Streptococcus Pneumoniae Vaccines"],"interventions":[{"type":"BIOLOGICAL","name":"Pneumococcal conjugate vaccine GSK1024850A","otherNames":[]},{"type":"BIOLOGICAL","name":"Prevenar","otherNames":["Pneumococcal conjugate vaccine (Wyeth Lederle)."]},{"type":"BIOLOGICAL","name":"Infanrix hexa","otherNames":["DTPa-HBV-IPV/Hib (GSK Biologicals)."]},{"type":"BIOLOGICAL","name":"Infanrix IPV Hib","otherNames":["DTPa-IPV/Hib (GSK Biologicals)."]},{"type":"BIOLOGICAL","name":"Infanrix penta","otherNames":["DTPa-HBV-IPV (GSK Biologicals)."]},{"type":"BIOLOGICAL","name":"Infanrix IPV","otherNames":["DTPa-IPV (GSK Biologicals)"]},{"type":"BIOLOGICAL","name":"Meningitec","otherNames":["Meningococcal C conjugate vaccine (Wyeth)."]},{"type":"BIOLOGICAL","name":"NeisVac-C","otherNames":["Meningococcal C conjugate vaccine (Baxter)."]},{"type":"BIOLOGICAL","name":"Menitorix","otherNames":["Combined Hib-MenC vaccine (GSK Biologicals)."]}],"arms":[{"label":"GSK's 10-valent Pneumococcal Vaccine 1024850A + Meningitec™","type":"EXPERIMENTAL"},{"label":"GSK's 10-valent Pneumococcal Vaccine 1024850A + NeisVac-C™","type":"EXPERIMENTAL"},{"label":"GSK's 10-valent Pneumococcal Vaccine 1024850A + Menitorix™","type":"EXPERIMENTAL"},{"label":"Prevenar™ + Menitorix™","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety in terms of fever (rectal temperature) higher than 39 degree Celcius (°C) and the immunogenicity in terms of antibody response following a booster vaccination with pneumococcal vaccine GSK1024850A at 11 to 18 months of age in children previously primed with the same vaccines including a pneumococcal conjugate vaccine co-administered with a diphtheria, tetanus, acellular pertussis (DTPa)-combined and meningococcal serogroup C (MenC) or combined meningococcal serogroup C and Haemophilus influenzae type b (Hib-MenC) vaccine.\n\nThis protocol posting deals with objectives \\& outcome measures of the booster phase. The objectives \\& outcome measures of the primary phase are presented in a separate protocol posting (NCT number = NCT00334334).","primaryOutcome":{"measure":"Number of Subjects Reporting Fever Above 39.0 Degree Celsius (°C)","timeFrame":"During the 4-day (Day 0-3) period after the booster vaccination","effectByArm":[{"arm":"GSK's 10-valent Pneumococcal Vaccine 1024850A + Menitorix™","deltaMin":11,"sd":null},{"arm":"Prevenar™ + Menitorix™","deltaMin":8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"11 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":13},"locations":{"siteCount":63,"countries":["Germany","Poland","Spain"]},"refs":{"pmids":["19325447","19325452","19325450","26954689"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":15},"commonTop":["Pain","Redness","Irritability","Swelling","Drowsiness"]}}